Irritable bowel syndrome and colonic diverticular disease: overlapping symptoms and overlapping therapeutic approaches

被引:14
作者
Alamo, Rommel Zerpa
Quigley, Eamonn M. M.
机构
[1] Houston Methodist Hosp, Lynda K & David M Underwood Ctr Digest Disorders, Div Gastroenterol & Hepatol, Houston, TX USA
[2] Weill Cornell Med Coll, Houston, TX USA
关键词
diverticular disease; diverticulosis; irritable bowel syndrome; symptomatic uncomplicated diverticular disease; GUT MICROBIOTA; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; RISK-FACTORS; RIFAXIMIN; COLITIS; PREVALENCE; PROBIOTICS; POPULATION; MESALAZINE;
D O I
10.1097/MOG.0000000000000499
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review Irritable bowel syndrome (IBS) is a common symptomatic disorder in the Western world and colonic diverticula are also prevalent; however, relationships between IBS-type symptoms and diverticula have been a source of much debate. Our goal was to reassess these relationships in the light of new data. Recent findings On removing from consideration clinical scenarios which are directly related to diverticula (i.e., diverticulitis, diverticular hemorrhage, and complications of diverticulitis, such as stricture and fistula), relationships between IBS and diverticula can be seen to revolve around a number of questions. First, are IBS and symptomatic uncomplicated diverticular disease (SUDD) the same condition? Or, in other words is SUDD no more than IBS in an individual who just happens to have diverticula? Although coincident IBS and diverticula inevitably do occur there is some evidence to indicate that SUDD may be somewhat distinctive with SUDD being characterized by more frequent and severe pain. Second, and analogous to interactions between IBS and inflammatory bowel disease or celiac disease, can an episode of acute diverticulitis lead to the de novo development of IBS? There is now epidemiological and pathophysiological evidence to support this occurrence. Summary Although relationships between uncomplicated diverticular disease and IBS have been reexamined their status remains unclear. As yet, however, none of the newer concepts related to this relationship have led to new therapeutic approaches in IBS or diverticular disease.
引用
收藏
页码:27 / 33
页数:7
相关论文
共 65 条
[1]   Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome [J].
Acosta, Andres ;
Camilleri, Michael ;
Shin, Andrea ;
Nord, Sara Linker ;
O'Neill, Jessica ;
Gray, Amber V. ;
Lueke, Alan J. ;
Donato, Leslie J. ;
Burton, Duane D. ;
Szarka, Lawrence A. ;
Zinsmeister, Alan R. ;
Golden, Pamela L. ;
Fodor, Anthony .
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2016, 7
[2]   Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease [J].
Barbara, Giovanni ;
Scaioli, Eleonora ;
Barbaro, Maria Raffaella ;
Biagi, Elena ;
Laghi, Luca ;
Cremon, Cesare ;
Marasco, Giovanni ;
Colecchia, Antonio ;
Picone, Gianfranco ;
Salfi, Nunzio ;
Capozzi, Francesco ;
Brigidi, Patrizia ;
Festi, Davide .
GUT, 2017, 66 (07) :1252-1261
[3]   Randomised controlled trial of mesalazine in IBS [J].
Barbara, Giovanni ;
Cremon, Cesare ;
Annese, Vito ;
Basilisco, Guido ;
Bazzoli, Franco ;
Bellini, Massimo ;
Benedetti, Antonio ;
Benini, Luigi ;
Bossa, Fabrizio ;
Buldrini, Paola ;
Cicala, Michele ;
Cuomo, Rosario ;
Germana, Bastianello ;
Molteni, Paola ;
Neri, Matteo ;
Rodi, Marcello ;
Saggioro, Alfredo ;
Scribano, Maria Lia ;
Vecchi, Maurizio ;
Zoli, Giorgio ;
Corinaldesi, Roberto ;
Stanghellini, Vincenzo .
GUT, 2016, 65 (01) :82-90
[4]   Post-infectious irritable bowel syndrome: Mechanistic insights into chronic disturbances following enteric infection [J].
Beatty, Jennifer K. ;
Bhargava, Amol ;
Buret, Andre G. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) :3976-3985
[5]   Meta-analysis: long-term therapy with rifaximin in the management of uncomplicated diverticular disease [J].
Bianchi, M. ;
Festa, V. ;
Moretti, A. ;
Ciaco, A. ;
Mangone, M. ;
Tornatore, V. ;
Dezi, A. ;
Luchetti, R. ;
De Pascalis, B. ;
Papi, C. ;
Koch, M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (08) :902-910
[6]   The epidemiology of irritable bowel syndrome [J].
Canavan, Caroline ;
West, Joe ;
Card, Timothy .
CLINICAL EPIDEMIOLOGY, 2014, 6 :71-80
[7]   Genetic polymorphism in pathogenesis of irritable bowel syndrome [J].
Cheung, Cynthia K. Y. ;
Wu, Justin C. Y. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (47) :17693-17698
[8]   Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome [J].
Chumpitazi, B. P. ;
Cope, J. L. ;
Hollister, E. B. ;
Tsai, C. M. ;
McMeans, A. R. ;
Luna, R. A. ;
Versalovic, J. ;
Shulman, R. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) :418-427
[9]   Increased Risk for Irritable Bowel Syndrome After Acute Diverticulitis [J].
Cohen, Erica ;
Fuller, Garth ;
Bolus, Roger ;
Modi, Rusha ;
Vu, Michelle ;
Shahedi, Kamyar ;
Shah, Rena ;
Atia, Mary ;
Kurzbard, Nicole ;
Sheen, Victoria ;
Agarwal, Nikhil ;
Kaneshiro, Marc ;
Yen, Linnette ;
Hodgkins, Paul ;
Erder, M. Haim ;
Spiegel, Brennan .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (12) :1614-1619
[10]   Italian consensus conference for colonic diverticulosis and diverticular disease [J].
Cuomo, Rosario ;
Barbara, Giovanni ;
Pace, Fabio ;
Annese, Vito ;
Bassotti, Gabrio ;
Binda, Gian A. ;
Casetti, Tino ;
Colecchia, Antonio ;
Festi, Davide ;
Fiocca, Roberto ;
Laghi, Andrea ;
Maconi, Giovanni ;
Nascimbeni, Riccardo ;
Scarpignato, Carmelo ;
Villanacci, Vincenzo ;
Annibale, Bruno .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2014, 2 (05) :413-442